Tegtmeyer C J, Teates C D, Crigler N, Gandee R W, Ayers C R, Stoddard M, Wellons H A
Radiology. 1981 Aug;140(2):323-30. doi: 10.1148/radiology.140.2.7255705.
Fifty renal artery stenoses in 38 hypertensive patients were treated with percutaneous transluminal angioplasty. Follow-up over a period of 1 to 24 months (mean, 9 mo.), including angiography, renal vein renin determinations, and radionuclide flow studies, were performed in 24 patients (32 stenoses). The initial dilatation was successful in 90% of stenoses and redilatation was necessary in 22% with a success rate of 84%. The mean systolic pressure decreased by 65.83 mm Hg and the mean diastolic pressure by 35.88 mm Hg in response to the treatment. Sixteen patients were cured, 18 were felt to have better control of blood pressure on medication, and 4 were not helped. Percutaneous transluminal angioplasty appears to be a technically feasible and clinically effective method of treating renovascular hypertension.
对38例高血压患者的50处肾动脉狭窄进行了经皮腔内血管成形术治疗。对24例患者(32处狭窄)进行了为期1至24个月(平均9个月)的随访,包括血管造影、肾静脉肾素测定和放射性核素血流研究。初始扩张在90%的狭窄中成功,22%的患者需要再次扩张,成功率为84%。治疗后平均收缩压下降65.83 mmHg,平均舒张压下降35.88 mmHg。16例患者治愈,18例患者通过药物治疗血压得到更好控制,4例患者未获改善。经皮腔内血管成形术似乎是一种技术上可行且临床上有效的治疗肾血管性高血压的方法。